It is not every day that a new journal is launched. With this first issue, we are celebrating the birth of *JNCI Cancer Spectrum*, a new online, Open Access journal from Oxford University Press. *JNCI Cancer Spectrum* is a sister journal to the well-established, impactful and highly regarded *Journal of the National Cancer Institute*. It arises from a recognition that there is a need for a second journal in the *JNCI* family that provides rapid, rigorous peer review as well as the opportunity for immediate online, Open Access publication of important cancer research.

As Editor-in-Chief, I am pleased to announce that we are actively seeking submissions to this new journal. I have assembled a team of Associate Editors (<https://academic.oup.com/jncics/pages/Editorial_Board>) who have broad expertise in cancer research who will play an integral role in the success of our new Journal. Our Consulting Statistician will help to ensure the highest standards of statistical reporting in the papers we publish. Recognizing that our content areas overlap with *JNCI*, we will publish high-quality research in a broad range of cancer-related areas, from basic to translational to epidemiological and clinical research, including health services and policy as well as psychosocial and palliative care research. Specifically, we invite manuscripts that report novel and/or hypothesis-generating results, outcomes of clinical trials, and high-quality replications of previously reported findings, as well as meta-analyses, critical appraisals, and expert opinion reviews of important areas in cancer research.

One of the novel aspects of our Journal will be the publication of scholarly discussions of emerging research hypotheses and future research directions. We strongly encourage submission of manuscripts in these categories, and we anticipate that *JNCI Cancer Spectrum* will become a "home" for these discussions and that these papers will become important drivers of research direction. We also invite impactful commentaries on important cancer-related issues.

We will share many of the strengths of our sister journal, *JNCI*, which currently receives more high-quality manuscripts than it can publish---as a result, at times, authors of manuscripts submitted to *JNCI* will be invited to transfer their manuscripts to *JNCI Cancer Spectrum*. We encourage authors to accept these invitations as their papers will undergo expedited review at *JNCI Cancer Spectrum*, using the reviews that have already been obtained at *JNCI*, leading to more rapid publication than would otherwise be possible. We share staff with *JNCI* to maintain the high quality of peer review and experience associated with the *JNCI* brand.

The scientific publishing world is changing. Increasingly, funders of cancer research are requiring that the results of the research they fund will be published with Open Access---this is reflected in the model *JNCI Cancer Spectrum* has adopted. We will make every effort to maintain low publication costs for the manuscripts we publish, and we will waive publishing fees when they represent an obstacle to publication of high-quality research. We will publish on the *JNCI Cancer Spectrum* website (<https://academic.oup.com/jncics>); our goal is to be indexed on PubMed in the near future, with all published papers accessible through PubMed Central.

I invite you to submit your manuscripts to *JNCI Cancer Spectrum*---we will provide rapid and fair peer review, as well as timely, Open Access publication.
